Beacon Venture Capital, the VC arm of Thailand-based Kasikorn Bank, has launched a fund aimed at financial technology start-ups with a corpus of THB1 billion ($29 million).
At a time when websites have never seemed more vulnerable, CounterTack has a software solution that can plug holes in online security systems. It has raised $20 million in Series D funding to support expansion
MoneySmart, a personal finance portal backed by Golden Gate Ventures, has received a $10 million Series B funding round led by Japanese shopping price comparison site operator Kakaku.
Singapore-based cloud communications platform Wavecell has raised an $8.2 million Series B round led by Qualgro, a VC firm active in Southeast Asia and Australia.
Swiggy plans to use its $80 million Series E round of funding to challenge the likes of Zomato and Food Panda for market leadership in India's online food delivery industry
Chinese intercity courier services provider Shansong has secured an extended Series C round of funding led by Shunwei Capital Partners and Chinese retailer Beijing Hualian Group.
Sequoia Capital has topped up its fourth India fund – having closed the fifth country vehicle early last year – and disclosed that its most recent China growth vehicle closed at $899.5 million.
The China Securities Regulatory Commission (CSRC) has eased rules for private equity and venture capital firms by reducing their post-IPO lock-up period in an A-share listed companies from three years to one year.
Australia’s OneVentures has invested A$10 million ($7.4 million) in Prota Therapeutics, a domestic immunotherapy technology developer aiming to commercialize new peanut allergy treatments for children.
SingTel Innov8, the venture arm of Singapore telecom giant SingTel, has co-led a $20 million Series D round for US and Singapore-based cybersecurity company CoutnerTack alongside US-based SAP National Security Services.
OrbiMed Asia Partners has led a $19 million Series B round of funding for InventisBio, a pharmaceutical developer based in Shanghai with operations in China and the US.
IP Group, which specializes in commercializing intellectual property, has raised a new round of funding from investors including Temasek Holdings and Telstra Super, and pledged to invest A$200 million ($149 million) in Australia and New Zealand.
Having built its business by licensing mobile software to smart phone manufacturers, China's Chubao has raised $100 million to bankroll a freemium model that will allow it to interact directly with users
Australia’s growing technology sector is set to benefit from long-term socioeconomic trends in Asia. Success will depend on both operational tenacity and a fundamental shift in expansion philosophy
China-based healthcare specialist Lyfe Capital has raised more than $420 million for its second fund, which comprises parallel US dollar and renminbi-denominated tranches.
Warburg Pincus has led a $120 million round of funding for China’s Yuanfudao in what is said to be the largest-ever PE investment in the country's online tutoring industry.
South African internet conglomerate Naspers Group has led a Series E round of funding worth $80 million for Swiggy, an India-based online food-ordering and delivery platform.
Action Potential Venture Capital (APVC), an investment arm of British pharmaceutical company GlaxoSmithKline, has led a A$53 million ($40 million) all-equity Series D round for Australia’s Saluda Medical.
Sequoia Capital China has co-led a funding round for online reading business Zongheng Literature, working in tandem with Perfect World, the Chinese movies-to-gaming company that controls Zongheng.
The disruption caused by technology in China's consumer and business services sectors - and the change this brings to traditional business models - is generating increased deal flow for private equity and venture capital investors.
The venture capital division of South African media firm Naspers has invested $5 million in Coins, a US-founded blockchain and financial technology company operating in the Philippines.
Lechebang, a Chinese online automobile services platform focused on after-sale services, has completed a RMB300 million ($44 million) Series B round led by Grand Flight Investment.
Investors are looking to tap the massive potential of China’s genomic industry, with a particular focus on companies that leverage large amounts of patient data to support drug development and testing services
CANbridge Life Science, a Beijing-based clinical-stage biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has raised a Series B round worth $25 million.